Based on recent data, Sunshine Biopharma, Inc. (SBFM) shows an Average True Range (ATR) of 0.05 and an Enterprise Value of -14.71M. Its average trading volume over the past 3 months is 1.48M, indicating liquidity. These fundamental metrics provide insight into SBFM's underlying financial health and market activity.
| ATR | 0.05 |
| Enterprise Value | -14.71M |
| Avg Vol (3 Months) | 1.48M |
| Avg Vol (10 Days) | 610.16K |
Sunshine Biopharma, Inc. (SBFM) technical indicators as of August 7, 2026: the SMA 20 is 3.27%, SMA 50 at -1.83%, and SMA 200 at -16.03%. The RSI 14 value is 53.25, suggesting its current momentum. These technical analysis signals help assess SBFM's price trends and potential future movements.
| SMA 20 | 3.27% |
| SMA 50 | -1.83% |
| SMA 200 | -16.03% |
| RSI 14 | 53.25 |
Sunshine Biopharma, Inc. (SBFM) stock performance overview as of August 7, 2026: The 52-week high is $24.3 (currently -68.46% below), and the 52-week low is $1.1 (currently 8.85% above). Over the past year, SBFM's performance is -57.24%, compared to the S&P 500's 4.18% change.
| 52-Week High | 24.3 |
| 52-Week High Chg | -68.46% |
| 52-Week Low | 1.1 |
| 52-Week Low Chg | +8.85% |
| S&P 500 52-Week Chg | 4.18% |
According to market data, Sunshine Biopharma, Inc. (SBFM) stock's recent performance metrics show that over the last month, SBFM is -12.95%, with a Year-to-Date (YTD) performance of -1.63%. Over the past year, the stock has seen a -57.24% change. These figures summarize SBFM's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.52 | 2.14 | 23.2 | 23.2 | 24.3 | 23.2 |
| Low | 1.12 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Performance | -4.72% | -12.95% | -42.11% | -22.44% | -57.24% | -1.63% |
According to current financial data, SBFM stock's P/E (TTM) ratio is -0.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SBFM, including P/S (0.09), P/B (0.03), and P/FCF (-0.61), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SBFM | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.02 | -1.24 | 14.22 | 32.59 |
| P/S (TTM) | 0.09 | 3.71 | 5.78 | 5.98 |
| P/B (TTM) | 0.03 | 0.68 | 24.28 | 5.6 |
| P/FCF (TTM) | -0.61 | -59.26 | -23.9 | 31.69 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep